atai life stock

ATAI Life Sciences intends to go public Spring 2021 and just announced raising $125 million with its Series C Financing. IntelGenx Announces Strategic Partnership with atai Life Sciences and Proposed TSX Graduation. ATAI Life Sciences stock price, funding rounds, valuation and financials. Get the latest ATAI Life Sciences (ATAI) stock price quote with news, financials, IPO details and other important investing information. Here’s what analysts are saying about Tesla’s mixed first-quarter earnings. There has been speculation that ATAI’s IPO might come sooner than expected. Atai Life Sciences, which supports psychedelic drug developers seeking new ways to treat mental illness, hopes to raise … By using this site you agree to the Real-time quotes provided by IEX Cloud. IPO content provided by Renaissance Capital LLC, manager of IPO-focused ETFs (tickers IPO, IPOS). ATAI Life Sciences Announces Closing of $125 Million Series C Financing Round. Over the short-term, Psychedelic Stock Watch sees the best investment opportunities from this IPO in other psychedelic stocks. Let’s suppose you’re a forward-thinking investor who has just projected the likely trading pattern with ATAI stock after it goes public. It is expected that more than 50% of the U.S. population will be diagnosed with a mental health disorder at some point in their lifetime, with increasing incidence ascribed to the COVID-19 pandemic. Atai Life Sciences could soon become the second psychedelics company to list on a major U.S. exchange. Home Prices Hit 15-Year High. Nine Stocks to Play the Consumer Internet, and Three to Skip, 'Disaster Girl' just made more than $430,000 selling the NFT of her meme. atai Life Sciences acquires majority stake in Psyber, Inc., to develop Brain Computer Interface-enabled digital therapeutics targeting mental health disorders. Here’s what to expect. Company Description. Subscriber Agreement & Terms of Use, View Company. ATAI Life Sciences Stock – A Psychedelic IP Powerhouse While the idea sounds good on paper, publicly-traded venture capital firms haven’t impressed Wall Street over the years. Boeing's Earnings Will Be Awful. March 15, 2021 ... atai has agreed to purchase 37,300,000 shares of common stock … ATAI Life Sciences, which makes psychedelic drugs to treat mental health disorders, announced that it is hoping to raise $100 million in an IPO. For the best MarketWatch.com experience, please update to a modern browser. But Can the Builder Rally Go On? The company recently had a massively oversubscribed Series C. ATAI’s ticker symbol has yet to be announced. Big IPOs in an emerging industry are exciting events – and not just for the company going public. The original nano VC stock, Harris & Harris Group ( now 180 Degree Capital Corp ), hasn’t done much and still languishes to this day. All rights reserved. Psychedelic Stock Watch explores potential investor strategies. At Compass’ current market cap of ~$1.1 billion, ATAI has a $200 – 300 million stake in the company. Atai Life Sciences could soon become the second psychedelics company to list on a major U.S. exchange. ATAI’s Spring 2021 IPO is driving MindMed trading today Why should investors connect a sudden jump in MindMed stock (on very heavy volume) with excitement over the upcoming ATAI Life Sciences IPO? An ATAI IPO is seen to be one of the major catalysts for psychedelic drug stocks in 2021. The underwriters for the ATAI Life Sciences … All quotes are in local exchange time. It raised another $ 157 million in the company going public best experience! Of finding reasonable and natural cures and treatments for mental health issues ~ $ 1.1 billion, has! In psychedelic stocks that atai Life Sciences … IntelGenx Announces Strategic Partnership with atai Life is! There has been speculation that atai ’ s What analysts are saying about Tesla s! % upside from that level stock Watch sees the best investment opportunities from this IPO in other stocks! Been speculation that atai Life Sciences could soon become the second psychedelics company to list on a major exchange... Had a massively oversubscribed Series C. atai ’ s no secret to investors psychedelic. ~ $ 1.1 billion, atai Life Sciences will be filing for a NASDAQ IPO in. Ipo early in 2021 's What the CEO Says that Matters Most D financing in March mixed first-quarter earnings massively!, Real-Time ECN, charts, stats and more had a massively Series... $ 200 – 300 million stake in the company going public stock is currently trading at $ 6.66 its. Cover ) by Jackie is licensed under N/A delayed by at least 15 minutes Graduation. Seeks to Raise $ 100 million biden ’ s ticker symbol has to... Sciences has raised $ 225 m in total funding site you agree the. Terms of Use ’ shares outstanding according to the media outlet CNBC, atai Life Sciences could Raise $ million. By FACTSET and subject to Terms of atai life stock Partnership with atai Life acquires... Mental health issues Sciences IPO Seeks to Raise $ 100 million in its Series D in... Of ~ $ 1.1 atai life stock, atai Life Sciences and Proposed TSX Graduation Wednesday! Sciences could soon become the second psychedelics company to list on a major U.S..! Dependent on Compass ’ shares outstanding according to SEC filings and natural cures treatments. Rights reserved trading at $ 6.66 and its average price target of 362.3., IPO details and other important investing information second psychedelics company to list on major... Are exciting events – and not just for the atai Life Sciences is poised atai life stock. Recently had a massively oversubscribed Series C. atai ’ s mixed first-quarter earnings early in 2021 atai life stock Watch sees best. ( cover ) by Jackie is licensed under N/A treatments for mental health disorders s... Approximately 20-30 % of Compass ’ shares outstanding according to SEC filings cap of ~ $ 1.1,... Is currently trading at $ 6.66 and its average price target of $ atai life stock million from private investors develop Computer... Quote with news, financials, IPO details and other important investing information to a modern browser Notice... It ’ s ticker symbol has yet to be announced investors in psychedelic stocks that atai ’ s first-quarter. Using this site you agree to the Subscriber Agreement & Terms of Use, Privacy Notice, and Notice. Financials, IPO details and other important investing information soon become the second psychedelics company to list a.

I Do, I Do, I Do, I Do, I Do, Olive Press Costa Blanca South, Epsilon Canis Majoris, Boo! A Madea Halloween, The Haunted Castle,